UOC
REPL icon

UBS O'Connor’s Replimune Group REPL Stock Holding History

UBS O'Connor’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-114,082
Closed -$1.06M – 421
2025
Q2 		$1.06M Sell
114,082
-136,338
-54% -$1.19M 0.03% 209
2025
Q1 		$2.44M Buy
250,420
+8,850
+4% +$110K 0.06% 113
2024
Q4 		$2.93M Buy
241,570
+48,448
+25% +$589K 0.07% 124
2024
Q3 		$2.12M Sell
193,122
-13,314
-6% -$135K 0.05% 165
2024
Q2 		$1.86M Buy
206,436
+113,445
+122% +$791K 0.05% 202
2024
Q1 		$760K Sell
92,991
-7,009
-7% -$57.5K 0.02% 301
2023
Q4 		$843K Buy
+100,000
New +$1.16M 0.03% 292
2023
Q2 		– Sell
-39,500
Closed -$698K – 633
2023
Q1 		$698K Buy
+39,500
New +$939K 0.02% 437
2019
Q3 		– Sell
-28,200
Closed -$413K – 357
2019
Q2 		$413K Sell
28,200
-26,382
-48% -$381K 0.01% 203
2019
Q1 		$831K Sell
54,582
-13,949
-20% -$174K 0.02% 188
2018
Q4 		$685K Buy
68,531
+15,866
+30% +$214K 0.02% 182
2018
Q3 		$848K Buy
+52,665
New +$923K 0.02% 214

Other funds holding REPL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

UBS O'Connor's REPL Position: Q3 2025 in Review

UBS O'Connor sold out of Replimune Group (REPL) in Q3 2025, closing a stake of 114,082 shares — an estimated $1.06M sold.

UBS O'Connor first reported a position in REPL in Q3 2018 and held it in 12 quarters. The position peaked at $2.93M in Q4 2024. 163 funds tracked by Wall St. Rank hold REPL as of Q3 2025.

  • UBS O'Connor reported no remaining Replimune Group position as of Q3 2025 after selling out during the quarter.
  • UBS O'Connor sold 114,082 Replimune Group shares in Q3 2025, an estimated $1.06M.
  • UBS O'Connor first reported a position in Replimune Group in Q3 2018 and held it in 12 quarters.
  • UBS O'Connor's Replimune Group position peaked at $2.93M in Q4 2024.
  • 163 funds tracked by Wall St. Rank held Replimune Group as of Q3 2025.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.